Reply by Authors

J Urol. 2022 Dec;208(6):1192-1193. doi: 10.1097/JU.0000000000002922.02. Epub 2022 Dec 1.

Authors

Bruce J Trock^{1

2}, Yuezhou Jing¹, Brent Mabey³, Zaina Sangale³, Lauren Lenz³, Nora Haney¹, Igor Vidal⁴, Stephanie A Glavaris⁴, Gunes Guner⁴, Onur Ertunc⁴, Ibrahim Kulac⁴, Javier A Baena Del Valle⁴, Tracy Jones⁴, Misop Han¹, Alan W Partin^{1

2}, Todd Cohen³, Steven Stone³, Angelo M De Marzo^{1

2

4}

Affiliations

¹ James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.
² The Sidney Kimmel Comprehensive Cancer Institute at Johns Hopkins, Baltimore, Maryland.
³ Myriad Genetics, Inc., Salt Lake City, Utah.
⁴ Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland.

PMID: 36349916
DOI: 10.1097/JU.0000000000002922.02

No abstract available